Filing Details

Accession Number:
0001104659-21-114183
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-09-09 16:03:36
Reporting Period:
2021-09-07
Accepted Time:
2021-09-09 16:03:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1554859 Semler Scientific Inc. SMLR Electromedical & Electrotherapeutic Apparatus (3845) 261367393
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1594342 Douglas Murphy-Chutorian C/O Semler Scientific, Inc.
2340-2348 Walsh Avenue, Suite 2344
Santa Clara CA 95051
Chief Executive Officer Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-09-07 1,154 $108.93 32,417 No 4 S Indirect By Trust
Common Stock Disposition 2021-09-07 96 $109.47 32,321 No 4 S Indirect By Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Trust
No 4 S Indirect By Trust
Footnotes
  1. Shares sold pursuant to a 10b5-1 trading plan.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.12 to $109.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 2 to this Form 4.
  3. Shares are held by the Murphy-Chutorian Family Trust U/D/T dated January 13, 1997, of which the Reporting Person is co-Trustee with his spouse.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.20 to $109.76, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 4 to this Form 4.